日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Xiaoyao San against depression via glia-mediated neuroinflammation using network pharmacology and experimental validation.

利用网络药理学和实验验证,逍遥散通过胶质细胞介导的神经炎症对抗抑郁症。

Liu Xin-Yi, Yan Yi-Zhi, Jiang An-Jun, He Wan-Ying, Fang Ying-Yan, Li Chao-Hui, Deng Man-Fei, Tan Si-Jie, Zeng Peng

P464: PULSE DOSING OF POTENT AND SELECTIVE HETEROBIFUNCTIONAL MDM2 DEGRADER KT-253 DRIVES TUMOR REGRESSION AND DEMONSTRATES DIFFERENTIATED PHARMACOLOGY COMPARED TO P53/MDM2 SMALL MOLECULE INHIBITORS

P464:强效选择性异功能MDM2降解剂KT-253的脉冲给药可驱动肿瘤消退,并显示出与P53/MDM2小分子抑制剂不同的药理学特性

Liu, Xin-Yi; Yan, Yi-Zhi; Jiang, An-Jun; He, Wan-Ying; Fang, Ying-Yan; Li, Chao-Hui; Deng, Man-Fei; Tan, Si-Jie; Zeng, Peng; Schalm, Stefanie; Chutake, Yogesh; Breitkopf, Susanne; Mayo, Michele; Dumont, Nancy; Chen, Dapeng; Dixit, Vaishali; Karnik, Rahul; Mcdonald, Alice; Filiatrault, Jessica; Proctor, William; Qi, Frank; Hu, Kan-Nian; Weiss, Matt; Gollerkeri, Ashwin; Sharma, Kirti; D Growney, Joseph; Williams, Juliet